Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature

This Mini Review of the literature aimed to assess the role of tocilizumab for the treatment of severe coronavirus disease 2019 (COVID-19). Based on the available scientific evidence, it is not clear to date what is the best therapeutic strategy for the treatment of COVID-19. Since SARS-CoV-2 infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacca, Erica, Digaetano, Margherita, Meschiari, Marianna, Franceschini, Erica, Menozzi, Marianna, Cuomo, Gianluca, Mussini, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699161/
https://www.ncbi.nlm.nih.gov/pubmed/33303188
http://dx.doi.org/10.1016/j.bbrc.2020.11.084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699161/
https://www.ncbi.nlm.nih.gov/pubmed/33303188
http://dx.doi.org/10.1016/j.bbrc.2020.11.084

Ejemplares similares